Parmenter et al. demonstrated that the suppression of glycolysis through BRAF inhibition in melanoma cells correlated with the downregulation of glucose transporters, GLUT1/3, and hexokinase 2 (HK2) expression [150]. Here, BRAF is linked to melanoma.